Cargando…

Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus

OBJECTIVE: Deferred revascularisation based upon fractional flow reserve (FFR >0.80) is associated with a low incidence of target lesion failure (TLF). Whether deferred revascularisation is also as safe in diabetes mellitus (DM) patients is unknown. METHODS: All DM patients and the next consecuti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kennedy, Mark W., Kaplan, Eliza, Hermanides, Rik S., Fabris, Enrico, Hemradj, Veemal, Koopmans, Petra C., Dambrink, Jan-Hank E., Marcel Gosselink, A. T., van‘t Hof, Arnoud W. J., Ottervanger, Jan Paul, Roolvink, Vincent, Remkes, Wouter S., van der Sluis, Aize, Suryapranata, Harry, Kedhi, Elvin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950234/ https://www.ncbi.nlm.nih.gov/pubmed/27431395 http://dx.doi.org/10.1186/s12933-016-0417-2

Ejemplares similares

Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a ‘real world’ prospective registry
por: Badings, E. A., et al.
Publicado: (2018)

Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores
por: Schellings, Dirk AAM, et al.
Publicado: (2016)

Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction
por: Remkes, Wouter S, et al.
Publicado: (2016)

Effects of radial versus femoral artery access in patients with acute myocardial infarction: A large centre prospective registry
por: Kilic, S., et al.
Publicado: (2016)

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
por: Fabris, Enrico, et al.
Publicado: (2022)

Are patients with non-ST elevation myocardial infarction undertreated?
por: Rasoul, Saman, et al.
Publicado: (2007)

Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience
por: Remkes, W. S., et al.
Publicado: (2017)

Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial
por: Fabris, Enrico, et al.
Publicado: (2020)

The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study
por: Postma, Sonja, et al.
Publicado: (2015)

Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study
por: Otten, Amber M, et al.
Publicado: (2013)

Impact of opioids on P2Y(12) receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
por: Tavenier, Anne H, et al.
Publicado: (2020)

The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]
por: van der Horst, Iwan CC, et al.
Publicado: (2005)

Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome
por: Badings, Erik A, et al.
Publicado: (2017)

The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients
por: Postma, S., et al.
Publicado: (2014)

Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?
por: Kennedy, Mark W., et al.
Publicado: (2017)

Single-staged transfemoral transcatheter aortic valve implantation and percutaneous coronary intervention with rotablation in complex coronary artery disease: a case report
por: Postma, Warner R, et al.
Publicado: (2018)

Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography
por: Hommels, Tobias Michiel, et al.
Publicado: (2023)

Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT–FFR) prospective study. Rationale and design
por: Kennedy, Mark W., et al.
Publicado: (2016)

Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study
por: Tolsma, Rudolf T, et al.
Publicado: (2021)

A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
por: Tavenier, A. H., et al.
Publicado: (2019)

Complex Large-Bore Radial percutaneous coronary intervention: rationale of the COLOR trial study protocol
por: Meijers, Thomas A, et al.
Publicado: (2020)

Final benefit of primary percutaneous coronary intervention for ST-elevation myocardial infarction in older patients: long-term results of a randomised trial
por: de Boer, M.-J., et al.
Publicado: (2022)

Outcomes of deferred revascularisation following negative fractional flow reserve in diabetic and non-diabetic patients: a meta-analysis
por: Ekmejian, Avedis, et al.
Publicado: (2023)

Sex Differences in Platelet Reactivity in Patients With ST-Elevation Myocardial Infarction: A Sub-Analysis of the ON-TIME 3 Trial
por: Tavenier, Anne H., et al.
Publicado: (2021)

Long‐term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions
por: Weerts, Jerremy, et al.
Publicado: (2020)

Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues
por: Verdoia, Monica, et al.
Publicado: (2020)

Survival and quality of life after surgical aortic valve replacement in octogenarians
por: Jansen Klomp, Wouter W., et al.
Publicado: (2016)

Early Discharge After Primary Percutaneous Coronary Intervention: The Added Value of N‐Terminal Pro–Brain Natriuretic Peptide to the Zwolle Risk Score
por: Schellings, Dirk A. A. M., et al.
Publicado: (2014)

Deferred
Publicado: (1885)

Deferred
Publicado: (1884)

Deferred
Publicado: (1884)

Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention
por: Negro, Federica, et al.
Publicado: (2021)

To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic Cardiomyopathy
por: Briceno, Natalia, et al.
Publicado: (2016)

Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention
por: Nardin, Matteo, et al.
Publicado: (2023)

To Defer or Not Defer? The Challenges of Physiology in Acute Coronary Syndromes
por: Campos, Carlos M., et al.
Publicado: (2018)

Hope Deferred
Publicado: (1891)

Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation
por: Verdoia, M., et al.
Publicado: (2016)

Physiology-guided myocardial revascularisation in complex multivessel coronary artery disease: beyond the 2014 ESC/EACTS guidelines on myocardial revascularisation
por: Piek, Jan J, et al.
Publicado: (2015)

MINOCA: The caveat of absence of coronary obstruction in myocardial infarction
por: Vranken, Nousjka P.A., et al.
Publicado: (2020)

Revascularisation for Ischaemic Cardiomyopathy
por: Li Kam Wa, Matthew E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ngems3aev5iko5jeadljgdffuu